A DOUBLE-BLIND-STUDY OF ZIMELIDINE, A SEROTONIN UPTAKE INHIBITOR, AND DESIPRAMINE, A NORADRENALINE UPTAKE INHIBITOR, IN ENDOGENOUS-DEPRESSION .1. CLINICAL FINDINGS

被引：55

作者：

ABERGWISTEDT, A

机构：

来源：

关键词：

D O I：

10.1111/j.1600-0447.1982.tb00914.x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：50 / 65

页数：16

共 58 条

[1] PRELIMINARY CLINICAL TEST OF ZIMELIDINE (H 102-09), A NEW 5-HT UPTAKE INHIBITOR
ABERG, A
HOLMBERG, G
[J]. ACTA PSYCHIATRICA SCANDINAVICA, 1979, 59 (01) : 45 - 58
[2] ABERG A, 1981, ACTA PSYCHIAT SCAND, V290, P224
[3] EFFECTS OF ZIMELIDINE AND DESIPRAMINE ON SEROTONIN AND NORADRENALINE UPTAKE MECHANISMS IN RELATION TO PLASMA-CONCENTRATIONS AND TO THERAPEUTIC EFFECTS DURING TREATMENT OF DEPRESSION
ABERGWISTEDT, A
JOSTELL, KG
ROSS, SB
WESTERLUND, D
[J]. PSYCHOPHARMACOLOGY, 1981, 74 (04) : 297 - 305
[4] AGREN H, 1981, ACTA U UPSAL, V405, P1
[5] STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY
ALEXANDERSON, B
EVANS, DAP
SJOQVIST, F
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686): : 764 - +
[6] [Anonymous], 1977, DRUG EXP CLIN RES
[7] ASBERG M, 1973, CLIN PHARMACOL THER, V14, P277
[8] ASBERG M, 1976, SCIENCE, V191, P478
[9] ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5
[10] ASBERG M, 1978, COMMUN PSYCHOPHARMAC, V2, P381